Alteration in TWIST expression: Possible role in paclitaxelinduced apoptosis in human laryngeal carcinoma Hep-2 cell line

Croatian Medical Journal

Volumn 50, Issue 6, 2009, Pages 536-542

  Yu, Liang ^a   Li, Hui Zheng ^a   Lu, Su Mei ^b   Liu, Wen Wen ^b   Li, Jian Feng ^b   Wang, Hai Bo ^a   Xu, Wei ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b Shandong Clinic Research Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE ORANGE; HELIX LOOP HELIX PROTEIN; MESSENGER RNA; PACLITAXEL; TRANSCRIPTION FACTOR TWIST;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; HEP 2 CELL; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA; CELL LINE, TUMOR; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; LARYNGEAL NEOPLASMS; PACLITAXEL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TWIST TRANSCRIPTION FACTOR;

EID: 75649123782     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2009.50.536     Document Type: Article

References (19)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23-47. Medline:11814064 doi:10.3322/canjclin.52.1.23.
2. Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer. 2002;97:72-81. Medline:11774246 doi:10.1002/ijc.1571. (Pubitemid 33104397)
3. F riboulet L, Pioche-Durieu C, Rodriguez S, Valent A, Souquere S, Ripoche H, et al. Recurrent overexpression Of C-Iap2 in Ebvassociated nasopharyngeal carcinomas: critical role in resistance to toll-like receptor 3-mediated apoptosis. Neoplasia. 2008;10:1183-94. Medline:18953427.
4. Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope. 2006;116:1-13. Medline:16946667 doi:10.1097/01. mlg.0000236095.97947.26. (Pubitemid 44270929)
5. Tishler RB, Busse PM, Norris CM Jr, Rossi R, Poulin M, Thornhill L, et al. An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignancies. Int J Radiat Oncol Biol Phys. 1999;43:1001-8. Medline:10192347 doi:10.1016/S0360- 3016(98)00533-1.
6. Haddad R, Tishler RB, Norris CM, Mahadevan A, Busse P, Wirth L, et al. Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment. Oncologist. 2003;8:35-44. Medline:12604730 doi:10.1634/theoncologist.8-1-35. (Pubitemid 36232354)
7. Haraf DJ, Rosen FR, Stenson K, Argiris A, Mittal BB, Witt ME, et al. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer. Clin Cancer Res. 2003;9:5936-43. Medline:14676118.
8. Thomadaki H, Talieri M, Scorilas A. Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS. Biol Chem. 2006;387:1081-6. Medline:16895478 doi:10.1515/BC.2006.133. (Pubitemid 44200502)
9. Li L, Jiang AC, Dong P, Wan Y, Yu ZW. The characteristics of Hep-2 cell with multiple drug resistance induced by Taxol. Otolaryngol Head Neck Surg. 2007;137:659-64. Medline:17903587 doi:10.1016/j.otohns.2007.04.026. (Pubitemid 47445893)
10. Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell. 2008;14:79-89. Medline:18598946 doi:10.1016/j.ccr.2008.06.005. (Pubitemid 351890463)
11. Cheng GZ, Zhang W, Wang LH. Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay. Cancer Res. 2008;68:957-60. Medline:18281467 doi:10.1158/0008-5472. CAN-07-5067.
12. Kajiyama H, Shibata K, Terauchi M, Yamashita M, Ino K, Nawa A, et al. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int J Oncol. 2007;31:277-83. Medline:17611683.
13. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 1986;89:271-7. Medline:3486233 doi:10.1016/0022-1759(86)90368- 6.
14. Gan Y, Wientjes MG, Schuller DE, Au JL. Pharmacodynamics of taxol in human head and neck tumors. Cancer Res. 1996;56:2086-93. Medline:8616855. (Pubitemid 26119910)
15. Wang TH, Wang HS, Soong YK. Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer. 2000;88:2619-28. Medline:10861441 doi:10.1002/1097-0142(20000601)88:11<26 19::AID-CNCR26>3.0.CO;2-J.
16. Wang X, Ling MT, Guan XY, Tsao SW, Cheung HW, Lee DT, et al. Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells. Oncogene. 2004;23:474-82. Medline:14724576 doi:10.1038/sj.onc.1207128. (Pubitemid 38175002)
17. Zhang X, Wang Q, Ling MT, Wong YC, Leung SC, Wang X. Antiapoptotic role of TWIST and its association with Akt pathway in mediating taxol resistance in nasopharyngeal carcinoma cells. Int J Cancer. 2007;120:1891-8. Medline:17230521 doi:10.1002/ijc.22489. (Pubitemid 46418364)
18. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature. 1979;277:665-7. Medline:423966 doi:10.1038/277665a0.
19. Syrigos KN, Karachalios D, Karapanagiotou EM, Nutting CM, Manolopoulos L, Harrington KJ. Head and neck cancer in the elderly: an overview on the treatment modalities. Cancer Treat Rev. 2009;35:237-45. Medline:19100689 doi:10.1016/j.ctrv.2008.11.002.